Skip to main content
. 2018 Sep 12;10:3433–3450. doi: 10.2147/CMAR.S169214

Table 3.

Correlation between KIF20A expression and the clinicopathological characteristics of epithelial ovarian cancer

Variable KIF20A expression
Spearman’s correlation coefficient P-value
Age 0.016 0.842
Histological type –0.54 0.518
FIGO stage 0.291 0.001
Intraperitoneal metastasis 0.354 <0.001
Lymph node metastasis 0.269 0.002
Intestinal metastasis 0.091 0.286
Vital status at last follow-up 0.475 <0.001
Tumor recurrence 0.231 0.005
Intraperitoneal recurrence 0.218 0.030
Distant recurrence –0.079 0.554
Residual tumor size (cm) 0.064 0.471
Differentiation grade –0.029 0.745
Neoadjuvant chemotherapy 0.152 0.064
Postoperative chemotherapy –0.029 0.726
HIPEC 0.106 0.216
Ascites with tumor cells 0.377 <0.001
Cytoreductive surgery –0.014 0.861
Drug resistance 0.329 0.012
CA125 (U/mL) –0.049 0.572
CA199 (U/mL) –0.125 0.149
CA153 (U/mL) 0.112 0.226
NSE (U/mL) –0.110 0.319
CEA (U/mL) 0.142 0.134
β-HCG (U/mL) 0.003 0.978

Abbreviations: β-HCG, β human choriogonadotropin; CEA, carcinoembryonic antigen; FIGO, International Federation of Gynecology and Obstetrics stage; HIPEC, hyperthermic intraperitoneal chemotherapy; NSE, neuron-specific enolase.